Bass D - Search Results

1

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea.

Zhang F, Bae SC, Bass D, Chu M, Egginton S, Gordon D, Roth DA, Zheng J, Tanaka Y. Zhang F, et al. Among authors: bass d. Ann Rheum Dis. 2018 Mar;77(3):355-363. doi: 10.1136/annrheumdis-2017-211631. Epub 2018 Jan 2. Ann Rheum Dis. 2018. PMID: 29295825 Free PMC article. Clinical Trial.

2

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.

Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. Stohl W, et al. Among authors: bass d. Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7. Arthritis Rheumatol. 2017. PMID: 28118533 Free PMC article. Clinical Trial.

3

A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus.

Chatham W, Chadha A, Fettiplace J, Kleoudis C, Bass D, Roth D, Gordon D. Chatham W, et al. Among authors: bass d. Lupus. 2017 Dec;26(14):1483-1490. doi: 10.1177/0961203317703495. Epub 2017 May 3. Lupus. 2017. PMID: 28467293 Free PMC article. Clinical Trial.

4

Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.

Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R, Hammer AE, Groark J, Bass D, Fox NL, Roth D, Gordon D. Doria A, et al. Among authors: bass d. Arthritis Rheumatol. 2018 Aug;70(8):1256-1264. doi: 10.1002/art.40511. Epub 2018 Jun 15. Arthritis Rheumatol. 2018. PMID: 29671280 Free PMC article. Clinical Trial.

5

Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial.

Tanaka Y, Bass D, Chu M, Egginton S, Ji B, Struemper H, Roth D. Tanaka Y, et al. Among authors: bass d. Mod Rheumatol. 2019 May;29(3):452-460. doi: 10.1080/14397595.2018.1480915. Epub 2018 Jul 20. Mod Rheumatol. 2019. PMID: 29792370 Clinical Trial.

6

A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus.

Doria A, Bass D, Schwarting A, Hammer A, Gordon D, Scheinberg M, Fox NL, Groark J, Stohl W, Kleoudis C, Roth D. Doria A, et al. Among authors: bass d. Lupus. 2018 Aug;27(9):1489-1498. doi: 10.1177/0961203318777634. Epub 2018 May 28. Lupus. 2018. PMID: 29807477 Free PMC article. Clinical Trial.

7

Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study.

van Vollenhoven RF, Stohl W, Furie RA, Fox NL, Groark JG, Bass D, Kurtinecz M, Pobiner BF, Eastman WJ, Gonzalez-Rivera T, Gordon D. van Vollenhoven RF, et al. Among authors: bass d. Lupus Sci Med. 2018 Nov 26;5(1):e000288. doi: 10.1136/lupus-2018-000288. eCollection 2018. Lupus Sci Med. 2018. PMID: 30588323 Free PMC article.

8

Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial.

Tanaka Y, Bass D, Chu M, Egginton S, Ji B, Roth D. Tanaka Y, et al. Among authors: bass d. Mod Rheumatol. 2020 Mar;30(2):313-320. doi: 10.1080/14397595.2019.1630897. Epub 2019 Jul 4. Mod Rheumatol. 2020. PMID: 31199180 Clinical Trial.

9

The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis.

Wilkinson C, Henderson RB, Jones-Leone AR, Flint SM, Lennon M, Levy RA, Ji B, Bass DL, Roth D. Wilkinson C, et al. Among authors: bass dl. Arthritis Res Ther. 2020 May 4;22(1):102. doi: 10.1186/s13075-020-02177-0. Arthritis Res Ther. 2020. PMID: 32366280 Free PMC article.

10

Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.

Mahajan A, Amelio J, Gairy K, Kaur G, Levy RA, Roth D, Bass D. Mahajan A, et al. Among authors: bass d. Lupus. 2020 Aug;29(9):1011-1020. doi: 10.1177/0961203320932219. Epub 2020 Jun 22. Lupus. 2020. PMID: 32571142 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

651 results

Search Page